Gene · 3276
Papers2,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FOXO nuclear shuttling dynamics are stimulus-dependent and correspond with cell fate. | Mol Biol Cell | 2023 | 36735481 | PubTator, text mining | PubMed |
| Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications. | Clin Mol Hepatol | 2023 | 36726054 | PubTator, text mining | PubMed |
| Activation of protein arginine methyltransferase 1 and subsequent extension of moth lifespan is effected by the ROS/JNK/CREB signaling axis. | J Biol Chem | 2023 | 36717080 | PubTator, text mining | PubMed |
| Differential chondrogenic differentiation between iPSC derived from healthy and OA cartilage is associated with changes in epigenetic regulation and metabolic transcriptomic signatures. | Elife | 2023 | 36715686 | PubTator, text mining | PubMed |
| Targeting epigenetic features in clear cell sarcomas based on patient-derived cell lines. | J Transl Med | 2023 | 36710341 | PubTator, text mining | PubMed |
| P300 Interacted With N-Myc and Regulated Its Protein Stability via Altering Its Post-Translational Modifications in Neuroblastoma. | Mol Cell Proteomics | 2023 | 36708875 | PubTator, text mining | PubMed |
| Recent advances in prostate cancer: WNT signaling, chromatin regulation, and transcriptional coregulators. | Asian J Androl | 2023 | 36695247 | PubTator, text mining | PubMed |
| METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey. | J Med Chem | 2023 | 36692498 | PubTator, text mining | PubMed |
| Advances and Highlights of miRNAs in Asthma: Biomarkers for Diagnosis and Treatment. | Int J Mol Sci | 2023 | 36675145 | PubTator, text mining | PubMed |
| Molecular Landscape of Tourette's Disorder. | Int J Mol Sci | 2023 | 36674940 | PubTator, text mining | PubMed |
| Targeting Epigenetic Mechanisms: A Boon for Cancer Immunotherapy. | Biomedicines | 2023 | 36672677 | PubTator, text mining | PubMed |
| Proteomic Discovery of Plasma Protein Biomarkers and Development of Models Predicting Prognosis of High-Grade Serous Ovarian Carcinoma. | Mol Cell Proteomics | 2023 | 36669591 | PubTator, text mining | PubMed |
| A New Phase of Networking: The Molecular Composition and Regulatory Dynamics of Mammalian Stress Granules. | Chem Rev | 2023 | 36662637 | PubTator, text mining | PubMed |
| Histone methylation in pre-cancerous liver diseases and hepatocellular carcinoma: recent overview. | Clin Transl Oncol | 2023 | 36650321 | PubTator, text mining | PubMed |
| PRMT1 driven PTX3 regulates ferritinophagy in glioma. | Autophagy | 2023 | 36647288 | PubTator, text mining | PubMed |
| Control of protein stability by post-translational modifications. | Nat Commun | 2023 | 36639369 | PubTator, text mining | PubMed |
| Multi-omics-based analysis of high grade serous ovarian cancer subtypes reveals distinct molecular processes linked to patient prognosis. | FEBS Open Bio | 2023 | 36637997 | PubTator, text mining | PubMed |
| PRMT3 regulates the progression of invasive micropapillary carcinoma of the breast. | Cancer Sci | 2023 | 36637351 | PubTator, text mining | PubMed |
| The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics. | Virol J | 2023 | 36627683 | PubTator, text mining | PubMed |
| The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer's Disease: New Potential Treatment Target. | Int J Mol Sci | 2023 | 36614305 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3276/papers?page=26